Lexicon Pharmaceuticals Income Statement (2009-2012) | LXRX

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012
Revenue & cost
Revenue 4.17M2.99M2.13M1.41M1.64M1.23M0.78M1.25M0.60M0.56M0.35M0.34M
Operating items
Research & Development 22.86M20.22M19.32M18.83M21.09M20.24M18.94M18.25M23.92M20.14M19.66M28.11M
Selling, General & Administrative 4.87M5.55M4.57M4.42M5.52M5.07M4.95M3.86M4.75M4.53M4.05M4.01M
Restructuring Costs 1.15M1.56M1.06M1.80M2.34M1.57M
Operating Expenses 27.74M25.77M23.89M23.26M26.61M25.31M25.03M23.68M29.73M26.48M26.05M33.69M
Operating Income -23.57M-22.78M-21.76M-21.85M-24.97M-24.07M-24.25M-22.43M-29.14M-25.93M-25.69M-33.34M
EBIT -23.57M-22.78M-21.76M-21.85M-24.97M-24.07M-24.25M-22.43M-29.14M-25.93M-25.69M-33.34M
Non-operating items
Non Operating Investment Income 0.01M0.31M0.18M1.17M0.09M0.05M0.04M
Interest & Investment Income 0.33M0.24M0.10M0.21M0.22M0.20M0.05M0.05M0.09M0.07M0.06M0.04M
Other Non Operating Income -0.94M-0.58M-0.52M-0.51M-0.68M-0.64M-2.70M0.00M0.03M0.09M0.01M
Non Operating Income -0.68M-0.64M-2.70M0.00M0.03M0.03M0.09M0.01M
Net income details
EBT -22.58M-21.81M-20.87M-26.78M-24.02M-24.60M-27.54M-23.00M-28.44M-26.67M-26.10M-33.84M
Tax Provisions -0.03M
Profit After Tax 24.34M-23.54M-22.67M-163.86M-26.07M-25.19M-27.51M-23.00M-29.63M-26.64M-26.10M-33.84M
Income from Non-Controlling Interests 2.78M3.47M3.53M-0.29M
Income from Continuing Operations -22.58M-21.81M-20.87M-26.78M-24.02M-24.60M-27.51M-23.00M-28.44M-26.67M-26.10M-33.84M
Consolidated Net Income -22.58M-21.81M-20.87M-26.78M-24.02M-24.60M-27.51M-23.00M-28.44M-26.67M-26.10M-33.84M
Income towards Parent Company -22.58M-21.81M-20.87M-26.78M-24.02M-24.60M-27.51M-23.00M-28.44M-26.67M-26.10M-33.84M
Net Income towards Common Stockholders -22.58M-21.81M-20.87M-26.78M-24.02M-24.60M-27.51M-23.00M-28.44M-26.67M-26.10M-33.84M
Additional items
EPS (Basic) -1.15-1.11-1.06-1.07-0.96-0.12-0.08-0.07-0.59-0.09-0.08-0.10
Shares Outstanding (Weighted Average) 19.62M19.62M19.62M25.10M25.09M48.20M48.20M48.22M48.23M48.24M48.24M48.24M68.65M68.67M70.62M
EBITDA -23.57M-22.78M-21.76M-21.85M-24.97M-24.07M-24.25M-22.43M-29.14M-25.93M-25.69M-33.34M
Interest Expenses -0.67M-0.73M-0.79M5.15M-0.73M0.73M0.64M0.63M-0.61M0.81M0.56M0.55M
Tax Rate 0.09%